PNC-27

PNC-27 is a synthetic membrane-penetrating peptide that fuses a p53-derived domain with a membrane-residency signal sequence. It serves as a specialized tool compound in oncology cell research for examining surface-expressed HDM-2 protein. Laboratory work centers on its behavior in cell-culture systems that model cancer-related membrane interactions. The peptide is supplied strictly for in-vitro and laboratory research use only.

In experimental models, PNC-27 is studied for its capacity to bind HDM-2 displayed on the plasma membrane of certain cancer cell lines. This binding is investigated as a trigger for pore formation that compromises membrane integrity and promotes necrotic cell death pathways. Researchers compare outcomes in HDM-2-overexpressing cells versus cells with lower surface HDM-2 to map selectivity. The design also enables probing of p53–HDM-2 interaction dynamics under controlled culture conditions.

PNC-27 is employed to investigate selective membrane disruption in HDM-2-overexpressing cancer cells within cell-culture platforms. Key research themes include necrotic cell-death mechanisms, membrane pore architecture, and the differential response of cells based on surface HDM-2 density. Additional studies explore how the peptide illuminates p53–HDM-2 binding interfaces in vitro. These lines of inquiry remain confined to laboratory model systems.

Cell-based experiments have shown that PNC-27 can induce rapid membrane permeabilization and necrotic features specifically in models overexpressing membrane HDM-2. Parallel observations indicate that cells expressing comparatively low levels of surface HDM-2 exhibit reduced membrane disruption under identical conditions. Such findings support the peptide’s utility as a probe for HDM-2-dependent membrane vulnerability. All reported data derive from controlled in-vitro systems.

PNC-27 should be handled according to standard laboratory peptide protocols, including cold storage and sterile reconstitution for cell assays. Investigators must account for its membrane-active character when selecting buffer conditions and exposure times. The compound is intended solely for in-vitro research and is not for human or animal consumption. Appropriate biosafety practices apply whenever cell-culture work involving PNC-27 is performed.